- call +1-201-465-4211
- email sales@marketsandresearch.biz
- Call +1-201-465-4211
- Email: sales@marketsandresearch.biz
The Flu Vaccine market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
According to our latest study, due to COVID-19 pandemic, the global Flu Vaccine market size is estimated to be worth US$ 5664.4 million in 2021 and is forecast to a readjusted size of USD 7756.9 million by 2028 with a CAGR of 4.6% during review period. For Children (6 months to 3 years) accounting for % of the Flu Vaccine global market in 2021, is projected to value USD million by 2028, growing at a % CAGR in next six years. While Trivalent Influenza Vaccine segment is altered to a % CAGR between 2022 and 2028.
Global key manufacturers of Flu Vaccine include Sanofi Pasteur, CSL, GSK, Mylan, and Hulan Bio, etc. In terms of revenue, the global top four players hold a share over % in 2021.
Market segmentation
Flu Vaccine market is split by Type and by Application. For the period 2017-2028, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type, covers
Trivalent Influenza Vaccine
Quadrivalent Influenza Vaccine
Market segment by Application can be divided into
For Children (6 months to 3 years)
For Adults and Children over 3 years
The key market players for global Flu Vaccine market are listed below:
Sanofi Pasteur
CSL
GSK
Mylan
Hulan Bio
AstraZeneca
CCBIO
Market segment by region, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Flu Vaccine product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Flu Vaccine, with price, sales, revenue and global market share of Flu Vaccine from 2019 to 2022.
Chapter 3, the Flu Vaccine competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Flu Vaccine breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2017 to 2028.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2017 to 2028.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2017 to 2022.and Flu Vaccine market forecast, by regions, type and application, with sales and revenue, from 2023 to 2028.
Chapter 12, the key raw materials and key suppliers, and industry chain of Flu Vaccine.
Chapter 13, 14, and 15, to describe Flu Vaccine sales channel, distributors, customers, research findings and conclusion, appendix and data source.
The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.
Market is segmented on the basis:
The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.
The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.
1 Market Overview
1.1 Flu Vaccine Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global Flu Vaccine Revenue by Type: 2017 Versus 2021 Versus 2028
1.2.2 Trivalent Influenza Vaccine
1.2.3 Quadrivalent Influenza Vaccine
1.3 Market Analysis by Application
1.3.1 Overview: Global Flu Vaccine Revenue by Application: 2017 Versus 2021 Versus 2028
1.3.2 For Children (6 months to 3 years)
1.3.3 For Adults and Children over 3 years
1.4 Global Flu Vaccine Market Size & Forecast
1.4.1 Global Flu Vaccine Sales in Value (2017 & 2021 & 2028)
1.4.2 Global Flu Vaccine Sales in Volume (2017-2028)
1.4.3 Global Flu Vaccine Price (2017-2028)
1.5 Global Flu Vaccine Production Capacity Analysis
1.5.1 Global Flu Vaccine Total Production Capacity (2017-2028)
1.5.2 Global Flu Vaccine Production Capacity by Geographic Region
1.6 Market Drivers, Restraints and Trends
1.6.1 Flu Vaccine Market Drivers
1.6.2 Flu Vaccine Market Restraints
1.6.3 Flu Vaccine Trends Analysis
2 Manufacturers Profiles
2.1 Sanofi Pasteur
2.1.1 Sanofi Pasteur Details
2.1.2 Sanofi Pasteur Major Business
2.1.3 Sanofi Pasteur Flu Vaccine Product and Services
2.1.4 Sanofi Pasteur Flu Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.2 CSL
2.2.1 CSL Details
2.2.2 CSL Major Business
2.2.3 CSL Flu Vaccine Product and Services
2.2.4 CSL Flu Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.3 GSK
2.3.1 GSK Details
2.3.2 GSK Major Business
2.3.3 GSK Flu Vaccine Product and Services
2.3.4 GSK Flu Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.4 Mylan
2.4.1 Mylan Details
2.4.2 Mylan Major Business
2.4.3 Mylan Flu Vaccine Product and Services
2.4.4 Mylan Flu Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.5 Hulan Bio
2.5.1 Hulan Bio Details
2.5.2 Hulan Bio Major Business
2.5.3 Hulan Bio Flu Vaccine Product and Services
2.5.4 Hulan Bio Flu Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.6 AstraZeneca
2.6.1 AstraZeneca Details
2.6.2 AstraZeneca Major Business
2.6.3 AstraZeneca Flu Vaccine Product and Services
2.6.4 AstraZeneca Flu Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.7 CCBIO
2.7.1 CCBIO Details
2.7.2 CCBIO Major Business
2.7.3 CCBIO Flu Vaccine Product and Services
2.7.4 CCBIO Flu Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
3 Flu Vaccine Breakdown Data by Manufacturer
3.1 Global Flu Vaccine Sales in Volume by Manufacturer (2019, 2020, 2021, and 2022)
3.2 Global Flu Vaccine Revenue by Manufacturer (2019, 2020, 2021, and 2022)
3.3 Key Manufacturer Market Position in Flu Vaccine
3.4 Market Concentration Rate
3.4.1 Top 3 Flu Vaccine Manufacturer Market Share in 2021
3.4.2 Top 6 Flu Vaccine Manufacturer Market Share in 2021
3.5 Global Flu Vaccine Production Capacity by Company: 2021 VS 2022
3.6 Manufacturer by Geography: Head Office and Flu Vaccine Production Site
3.7 New Entrant and Capacity Expansion Plans
3.8 Mergers & Acquisitions
4 Market Analysis by Region
4.1 Global Flu Vaccine Market Size by Region
4.1.1 Global Flu Vaccine Sales in Volume by Region (2017-2028)
4.1.2 Global Flu Vaccine Revenue by Region (2017-2028)
4.2 North America Flu Vaccine Revenue (2017-2028)
4.3 Europe Flu Vaccine Revenue (2017-2028)
4.4 Asia-Pacific Flu Vaccine Revenue (2017-2028)
4.5 South America Flu Vaccine Revenue (2017-2028)
4.6 Middle East and Africa Flu Vaccine Revenue (2017-2028)
5 Market Segment by Type
5.1 Global Flu Vaccine Sales in Volume by Type (2017-2028)
5.2 Global Flu Vaccine Revenue by Type (2017-2028)
5.3 Global Flu Vaccine Price by Type (2017-2028)
6 Market Segment by Application
6.1 Global Flu Vaccine Sales in Volume by Application (2017-2028)
6.2 Global Flu Vaccine Revenue by Application (2017-2028)
6.3 Global Flu Vaccine Price by Application (2017-2028)
7 North America by Country, by Type, and by Application
7.1 North America Flu Vaccine Sales by Type (2017-2028)
7.2 North America Flu Vaccine Sales by Application (2017-2028)
7.3 North America Flu Vaccine Market Size by Country
7.3.1 North America Flu Vaccine Sales in Volume by Country (2017-2028)
7.3.2 North America Flu Vaccine Revenue by Country (2017-2028)
7.3.3 United States Market Size and Forecast (2017-2028)
7.3.4 Canada Market Size and Forecast (2017-2028)
7.3.5 Mexico Market Size and Forecast (2017-2028)
8 Europe by Country, by Type, and by Application
8.1 Europe Flu Vaccine Sales by Type (2017-2028)
8.2 Europe Flu Vaccine Sales by Application (2017-2028)
8.3 Europe Flu Vaccine Market Size by Country
8.3.1 Europe Flu Vaccine Sales in Volume by Country (2017-2028)
8.3.2 Europe Flu Vaccine Revenue by Country (2017-2028)
8.3.3 Germany Market Size and Forecast (2017-2028)
8.3.4 France Market Size and Forecast (2017-2028)
8.3.5 United Kingdom Market Size and Forecast (2017-2028)
8.3.6 Russia Market Size and Forecast (2017-2028)
8.3.7 Italy Market Size and Forecast (2017-2028)
9 Asia-Pacific by Region, by Type, and by Application
9.1 Asia-Pacific Flu Vaccine Sales by Type (2017-2028)
9.2 Asia-Pacific Flu Vaccine Sales by Application (2017-2028)
9.3 Asia-Pacific Flu Vaccine Market Size by Region
9.3.1 Asia-Pacific Flu Vaccine Sales in Volume by Region (2017-2028)
9.3.2 Asia-Pacific Flu Vaccine Revenue by Region (2017-2028)
9.3.3 China Market Size and Forecast (2017-2028)
9.3.4 Japan Market Size and Forecast (2017-2028)
9.3.5 Korea Market Size and Forecast (2017-2028)
9.3.6 India Market Size and Forecast (2017-2028)
9.3.7 Southeast Asia Market Size and Forecast (2017-2028)
9.3.8 Australia Market Size and Forecast (2017-2028)
10 South America by Region, by Type, and by Application
10.1 South America Flu Vaccine Sales by Type (2017-2028)
10.2 South America Flu Vaccine Sales by Application (2017-2028)
10.3 South America Flu Vaccine Market Size by Country
10.3.1 South America Flu Vaccine Sales in Volume by Country (2017-2028)
10.3.2 South America Flu Vaccine Revenue by Country (2017-2028)
10.3.3 Brazil Market Size and Forecast (2017-2028)
10.3.4 Argentina Market Size and Forecast (2017-2028)
11 Middle East & Africa by Country, by Type, and by Application
11.1 Middle East & Africa Flu Vaccine Sales by Type (2017-2028)
11.2 Middle East & Africa Flu Vaccine Sales by Application (2017-2028)
11.3 Middle East & Africa Flu Vaccine Market Size by Country
11.3.1 Middle East & Africa Flu Vaccine Sales in Volume by Country (2017-2028)
11.3.2 Middle East & Africa Flu Vaccine Revenue by Country (2017-2028)
11.3.3 Turkey Market Size and Forecast (2017-2028)
11.3.4 Egypt Market Size and Forecast (2017-2028)
11.3.5 Saudi Arabia Market Size and Forecast (2017-2028)
11.3.6 South Africa Market Size and Forecast (2017-2028)
12 Raw Material and Industry Chain
12.1 Raw Material of Flu Vaccine and Key Manufacturers
12.2 Manufacturing Costs Percentage of Flu Vaccine
12.3 Flu Vaccine Production Process
12.4 Flu Vaccine Industrial Chain
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.2 Flu Vaccine Typical Distributors
13.3 Flu Vaccine Typical Customers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Research Process and Data Source
15.3 Disclaimer
List of Tables
Table 1. Global Flu Vaccine Revenue by Type, (USD Million), 2017 & 2021 & 2028
Table 2. Global Flu Vaccine Revenue by Application, (USD Million), 2017 & 2021 & 2028
Table 3. Sanofi Pasteur Basic Information, Manufacturing Base and Competitors
Table 4. Sanofi Pasteur Major Business
Table 5. Sanofi Pasteur Flu Vaccine Product and Services
Table 6. Sanofi Pasteur Flu Vaccine Sales (M Doses), Price (US$/Dose), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 7. CSL Basic Information, Manufacturing Base and Competitors
Table 8. CSL Major Business
Table 9. CSL Flu Vaccine Product and Services
Table 10. CSL Flu Vaccine Sales (M Doses), Price (US$/Dose), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 11. GSK Basic Information, Manufacturing Base and Competitors
Table 12. GSK Major Business
Table 13. GSK Flu Vaccine Product and Services
Table 14. GSK Flu Vaccine Sales (M Doses), Price (US$/Dose), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 15. Mylan Basic Information, Manufacturing Base and Competitors
Table 16. Mylan Major Business
Table 17. Mylan Flu Vaccine Product and Services
Table 18. Mylan Flu Vaccine Sales (M Doses), Price (US$/Dose), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 19. Hulan Bio Basic Information, Manufacturing Base and Competitors
Table 20. Hulan Bio Major Business
Table 21. Hulan Bio Flu Vaccine Product and Services
Table 22. Hulan Bio Flu Vaccine Sales (M Doses), Price (US$/Dose), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 23. AstraZeneca Basic Information, Manufacturing Base and Competitors
Table 24. AstraZeneca Major Business
Table 25. AstraZeneca Flu Vaccine Product and Services
Table 26. AstraZeneca Flu Vaccine Sales (M Doses), Price (US$/Dose), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 27. CCBIO Basic Information, Manufacturing Base and Competitors
Table 28. CCBIO Major Business
Table 29. CCBIO Flu Vaccine Product and Services
Table 30. CCBIO Flu Vaccine Sales (M Doses), Price (US$/Dose), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 31. Global Flu Vaccine Sales by Manufacturer (2019, 2020, 2021, and 2022) & (M Doses)
Table 32. Global Flu Vaccine Revenue by Manufacturer (2019, 2020, 2021, and 2022) & (USD Million)
Table 33. Market Position of Manufacturers in Flu Vaccine, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2021
Table 34. Global Flu Vaccine Production Capacity by Company, (M Doses): 2020 VS 2021
Table 35. Head Office and Flu Vaccine Production Site of Key Manufacturer
Table 36. Flu Vaccine New Entrant and Capacity Expansion Plans
Table 37. Flu Vaccine Mergers & Acquisitions in the Past Five Years
Table 38. Global Flu Vaccine Sales by Region (2017-2022) & (M Doses)
Table 39. Global Flu Vaccine Sales by Region (2023-2028) & (M Doses)
Table 40. Global Flu Vaccine Revenue by Region (2017-2022) & (USD Million)
Table 41. Global Flu Vaccine Revenue by Region (2023-2028) & (USD Million)
Table 42. Global Flu Vaccine Sales by Type (2017-2022) & (M Doses)
Table 43. Global Flu Vaccine Sales by Type (2023-2028) & (M Doses)
Table 44. Global Flu Vaccine Revenue by Type (2017-2022) & (USD Million)
Table 45. Global Flu Vaccine Revenue by Type (2023-2028) & (USD Million)
Table 46. Global Flu Vaccine Price by Type (2017-2022) & (US$/Dose)
Table 47. Global Flu Vaccine Price by Type (2023-2028) & (US$/Dose)
Table 48. Global Flu Vaccine Sales by Application (2017-2022) & (M Doses)
Table 49. Global Flu Vaccine Sales by Application (2023-2028) & (M Doses)
Table 50. Global Flu Vaccine Revenue by Application (2017-2022) & (USD Million)
Table 51. Global Flu Vaccine Revenue by Application (2023-2028) & (USD Million)
Table 52. Global Flu Vaccine Price by Application (2017-2022) & (US$/Dose)
Table 53. Global Flu Vaccine Price by Application (2023-2028) & (US$/Dose)
Table 54. North America Flu Vaccine Sales by Country (2017-2022) & (M Doses)
Table 55. North America Flu Vaccine Sales by Country (2023-2028) & (M Doses)
Table 56. North America Flu Vaccine Revenue by Country (2017-2022) & (USD Million)
Table 57. North America Flu Vaccine Revenue by Country (2023-2028) & (USD Million)
Table 58. North America Flu Vaccine Sales by Type (2017-2022) & (M Doses)
Table 59. North America Flu Vaccine Sales by Type (2023-2028) & (M Doses)
Table 60. North America Flu Vaccine Sales by Application (2017-2022) & (M Doses)
Table 61. North America Flu Vaccine Sales by Application (2023-2028) & (M Doses)
Table 62. Europe Flu Vaccine Sales by Country (2017-2022) & (M Doses)
Table 63. Europe Flu Vaccine Sales by Country (2023-2028) & (M Doses)
Table 64. Europe Flu Vaccine Revenue by Country (2017-2022) & (USD Million)
Table 65. Europe Flu Vaccine Revenue by Country (2023-2028) & (USD Million)
Table 66. Europe Flu Vaccine Sales by Type (2017-2022) & (M Doses)
Table 67. Europe Flu Vaccine Sales by Type (2023-2028) & (M Doses)
Table 68. Europe Flu Vaccine Sales by Application (2017-2022) & (M Doses)
Table 69. Europe Flu Vaccine Sales by Application (2023-2028) & (M Doses)
Table 70. Asia-Pacific Flu Vaccine Sales by Region (2017-2022) & (M Doses)
Table 71. Asia-Pacific Flu Vaccine Sales by Region (2023-2028) & (M Doses)
Table 72. Asia-Pacific Flu Vaccine Revenue by Region (2017-2022) & (USD Million)
Table 73. Asia-Pacific Flu Vaccine Revenue by Region (2023-2028) & (USD Million)
Table 74. Asia-Pacific Flu Vaccine Sales by Type (2017-2022) & (M Doses)
Table 75. Asia-Pacific Flu Vaccine Sales by Type (2023-2028) & (M Doses)
Table 76. Asia-Pacific Flu Vaccine Sales by Application (2017-2022) & (M Doses)
Table 77. Asia-Pacific Flu Vaccine Sales by Application (2023-2028) & (M Doses)
Table 78. South America Flu Vaccine Sales by Country (2017-2022) & (M Doses)
Table 79. South America Flu Vaccine Sales by Country (2023-2028) & (M Doses)
Table 80. South America Flu Vaccine Revenue by Country (2017-2022) & (USD Million)
Table 81. South America Flu Vaccine Revenue by Country (2023-2028) & (USD Million)
Table 82. South America Flu Vaccine Sales by Type (2017-2022) & (M Doses)
Table 83. South America Flu Vaccine Sales by Type (2023-2028) & (M Doses)
Table 84. South America Flu Vaccine Sales by Application (2017-2022) & (M Doses)
Table 85. South America Flu Vaccine Sales by Application (2023-2028) & (M Doses)
Table 86. Middle East & Africa Flu Vaccine Sales by Region (2017-2022) & (M Doses)
Table 87. Middle East & Africa Flu Vaccine Sales by Region (2023-2028) & (M Doses)
Table 88. Middle East & Africa Flu Vaccine Revenue by Region (2017-2022) & (USD Million)
Table 89. Middle East & Africa Flu Vaccine Revenue by Region (2023-2028) & (USD Million)
Table 90. Middle East & Africa Flu Vaccine Sales by Type (2017-2022) & (M Doses)
Table 91. Middle East & Africa Flu Vaccine Sales by Type (2023-2028) & (M Doses)
Table 92. Middle East & Africa Flu Vaccine Sales by Application (2017-2022) & (M Doses)
Table 93. Middle East & Africa Flu Vaccine Sales by Application (2023-2028) & (M Doses)
Table 94. Flu Vaccine Raw Material
Table 95. Key Manufacturers of Flu Vaccine Raw Materials
Table 96. Direct Channel Pros & Cons
Table 97. Indirect Channel Pros & Cons
Table 98. Flu Vaccine Typical Distributors
Table 99. Flu Vaccine Typical Customers
List of Figures
Figure 1. Flu Vaccine Picture
Figure 2. Global Flu Vaccine Revenue Market Share by Type in 2021
Figure 3. Trivalent Influenza Vaccine
Figure 4. Quadrivalent Influenza Vaccine
Figure 5. Global Flu Vaccine Revenue Market Share by Application in 2021
Figure 6. For Children (6 months to 3 years)
Figure 7. For Adults and Children over 3 years
Figure 8. Global Flu Vaccine Revenue, (USD Million) & (M Doses): 2017 & 2021 & 2028
Figure 9. Global Flu Vaccine Revenue and Forecast (2017-2028) & (USD Million)
Figure 10. Global Flu Vaccine Sales (2017-2028) & (M Doses)
Figure 11. Global Flu Vaccine Price (2017-2028) & (US$/Dose)
Figure 12. Global Flu Vaccine Production Capacity (2017-2028) & (M Doses)
Figure 13. Global Flu Vaccine Production Capacity by Geographic Region: 2022 VS 2028
Figure 14. Flu Vaccine Market Drivers
Figure 15. Flu Vaccine Market Restraints
Figure 16. Flu Vaccine Market Trends
Figure 17. Global Flu Vaccine Sales Market Share by Manufacturer in 2021
Figure 18. Global Flu Vaccine Revenue Market Share by Manufacturer in 2021
Figure 19. Flu Vaccine Market Share by Company Type (Tier 1, Tier 2, and Tier 3) in 2021
Figure 20. Top 3 Flu Vaccine Manufacturer (Revenue) Market Share in 2021
Figure 21. Top 6 Flu Vaccine Manufacturer (Revenue) Market Share in 2021
Figure 22. Global Flu Vaccine Sales Market Share by Region (2017-2028)
Figure 23. Global Flu Vaccine Revenue Market Share by Region (2017-2028)
Figure 24. North America Flu Vaccine Revenue (2017-2028) & (USD Million)
Figure 25. Europe Flu Vaccine Revenue (2017-2028) & (USD Million)
Figure 26. Asia-Pacific Flu Vaccine Revenue (2017-2028) & (USD Million)
Figure 27. South America Flu Vaccine Revenue (2017-2028) & (USD Million)
Figure 28. Middle East & Africa Flu Vaccine Revenue (2017-2028) & (USD Million)
Figure 29. Global Flu Vaccine Sales Market Share by Type (2017-2028)
Figure 30. Global Flu Vaccine Revenue Market Share by Type (2017-2028)
Figure 31. Global Flu Vaccine Price by Type (2017-2028) & (US$/Dose)
Figure 32. Global Flu Vaccine Sales Market Share by Application (2017-2028)
Figure 33. Global Flu Vaccine Revenue Market Share by Application (2017-2028)
Figure 34. Global Flu Vaccine Price by Application (2017-2028) & (US$/Dose)
Figure 35. North America Flu Vaccine Sales Market Share by Type (2017-2028)
Figure 36. North America Flu Vaccine Sales Market Share by Application (2017-2028)
Figure 37. North America Flu Vaccine Sales Market Share by Country (2017-2028)
Figure 38. North America Flu Vaccine Revenue Market Share by Country (2017-2028)
Figure 39. United States Flu Vaccine Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 40. Canada Flu Vaccine Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 41. Mexico Flu Vaccine Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 42. Europe Flu Vaccine Sales Market Share by Type (2017-2028)
Figure 43. Europe Flu Vaccine Sales Market Share by Application (2017-2028)
Figure 44. Europe Flu Vaccine Sales Market Share by Country (2017-2028)
Figure 45. Europe Flu Vaccine Revenue Market Share by Country (2017-2028)
Figure 46. Germany Flu Vaccine Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 47. France Flu Vaccine Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 48. United Kingdom Flu Vaccine Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 49. Russia Flu Vaccine Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 50. Italy Flu Vaccine Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 51. Asia-Pacific Flu Vaccine Sales Market Share by Region (2017-2028)
Figure 52. Asia-Pacific Flu Vaccine Sales Market Share by Application (2017-2028)
Figure 53. Asia-Pacific Flu Vaccine Sales Market Share by Region (2017-2028)
Figure 54. Asia-Pacific Flu Vaccine Revenue Market Share by Region (2017-2028)
Figure 55. China Flu Vaccine Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 56. Japan Flu Vaccine Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 57. Korea Flu Vaccine Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 58. India Flu Vaccine Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 59. Southeast Asia Flu Vaccine Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 60. Australia Flu Vaccine Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 61. South America Flu Vaccine Sales Market Share by Type (2017-2028)
Figure 62. South America Flu Vaccine Sales Market Share by Application (2017-2028)
Figure 63. South America Flu Vaccine Sales Market Share by Country (2017-2028)
Figure 64. South America Flu Vaccine Revenue Market Share by Country (2017-2028)
Figure 65. Brazil Flu Vaccine Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 66. Argentina Flu Vaccine Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 67. Middle East & Africa Flu Vaccine Sales Market Share by Type (2017-2028)
Figure 68. Middle East & Africa Flu Vaccine Sales Market Share by Application (2017-2028)
Figure 69. Middle East & Africa Flu Vaccine Sales Market Share by Region (2017-2028)
Figure 70. Middle East & Africa Flu Vaccine Revenue Market Share by Region (2017-2028)
Figure 71. Turkey Flu Vaccine Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 72. Egypt Flu Vaccine Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 73. Saudi Arabia Flu Vaccine Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 74. South Africa Flu Vaccine Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 75. Manufacturing Cost Structure Analysis of Flu Vaccine in 2021
Figure 76. Manufacturing Process Analysis of Flu Vaccine
Figure 77. Flu Vaccine Industrial Chain
Figure 78. Sales Channel: Direct Channel vs Indirect Channel
Figure 79. Methodology
Figure 80. Research Process and Data Source
Please feel free to write an email to us or to use our electronic ticketing system.
